Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Open in API
Filings indexed 1,031 across all filing types
Latest filing 2025-08-04 M&A Activity
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
OXURION_PR_Closing_Acquisition_FR.pdf
M&A Activity Classification · 99% confidence The document is a press release announcing the completion of an acquisition (72% of Axiodis CRO) by Oxurion. This falls under M&A activity, as it details a corporate acquisition strategy and the integration of a new business unit. It is not a report publication announcement, nor is it a financial report, but rather a specific announcement of a merger/acquisition transaction.
2025-08-04 French
OXURION_PR_Closing_Acquisition_NL.pdf
M&A Activity Classification · 100% confidence The document is a press release announcing the completion of an acquisition (Oxurion acquiring 72% of Axiodis CRO). This falls under M&A activity, which is categorized as 'TAR' (M&A Activity) in the provided filing definitions.
2025-08-04 Dutch
OXUR-Transparency-Notification-EN-20250723.pdf
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding a change in major shareholding (crossing a 15% threshold) by Atlas Special Opportunities II LLC in Oxurion NV. This is explicitly identified as a 'Transparency notification' under Belgian law, which corresponds to the 'Major Shareholding Notification' category.
2025-07-30 English
OXUR-Transparency-Notification-NL-20250723.pdf
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding a change in major shareholding (transparency notification) for Oxurion NV. It details that Atlas Special Opportunities II LLC has crossed a 15% threshold due to the disposal of voting securities. This aligns perfectly with the definition of a 'Major Shareholding Notification' (MRQ), which covers notifications of changes in significant share ownership levels.
2025-07-30 Dutch
OXUR-Transparency-Notification-EN-20250730.pdf
Major Shareholding Notification Classification · 100% confidence The document is a press release from Oxurion NV announcing that it has received a transparency notification regarding a change in major shareholding from Atlas Special Opportunities II LLC. The text explicitly mentions crossing a threshold (15%) due to the disposal of voting securities and includes the required regulatory 'Form TR-1 BE' annex. This fits the definition of a Major Shareholding Notification (MRQ).
2025-07-30 English
OXUR-Transparency-Notification-NL-20250730.pdf
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding a change in shareholding levels (transparantiekennisgeving) for Oxurion NV. It explicitly mentions that Atlas Special Opportunities II LLC crossed a 15% threshold due to the disposal of voting securities. This aligns perfectly with the definition of a Major Shareholding Notification, which tracks significant changes in ownership levels.
2025-07-30 Dutch

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.